US 9603907
Dry powder formulations of dNase I
granted A61KA61K33/06A61K33/14
Quick answer
US patent 9603907 (Dry powder formulations of dNase I) held by Protalix Ltd. expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protalix Ltd.
- Grant date
- Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K33/06, A61K33/14, A61K38/465, A61K38/47